Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Dotted line suggests plausible asymptotic relationship with exogenous GLP-1 medications that produce concentrations that are 1000x higher (ng/ml)
Virtas last announced round was a $133 million Series E in 2021, valuing the company at $2 billion
Whether twice-daily dosing produced better outcomes cannot be determined from self-reported data alone
Unlike shorter-acting GLP-1 agonists, semaglutide can be injected at any time of day, with or without food, maintaining therapeutic plasma concentrations throughout the week
The authors declare that they have no conflicts of interest
PubMed, Chen, Hao Yu, et al
US$ 20.65
US$ 22.30
/assets/production/practices/8b0d3bb90a4a057da79711c047bb7841fe69b974/images/2795992.jpg)
US$ 29.00
US$ 24.34
US$ 28.43
US$ 23.80
US$ 21.37
US$ 29.76
